跳至主要内容
临床试验/NCT00213733
NCT00213733已完成不适用

Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer

University Hospital, Strasbourg, France5 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2004年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
5

研究概览

简要总结

This is a prospective study of surgically resected samples and lymph nodes of lung cancer patients. For histopathologically positive lymph nodes from a complete resection, the investigators would like to analyse tumor tissue by allelotyping and comparing these results with those observed in the primary lung tumor to establish a cartography of molecular alteration in resected lung cancer. For non histopathologically positive lymph nodes, the investigators would like to research the presence (or not) of micrometastasis by allele-specific PCR (polymerase chain reaction).

详细描述

Genetic: It is a prospective study during two years with three years for follow-up. No control group is recruited.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with resectable non-small cell lung cancer (stage I to IIIA), with a complete resection of the tumor and paired lymph nodes.
  • Informed consent is required.

排除标准

  • Another cancer
  • Chemotherapy before surgical treatment

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other

研究点 (5)

Loading locations...

相似试验

Molecular Assessment of Lymph Nodes in Patients With... | 临床试验